Skip to main content

Table 4 The development of non- alcoholic fatty liver disease across quartiles of energy-adjusted daily magnesium intake

From: Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study

  Energy-adjusted daily magnesium intake
Q1(n = 250) Q2(n = 249) P-value* Q3(n = 250) P-value* Q4(n = 250) P-value *
Cases/control 70/180 65/185   55/194   36/214  
Range of energy-adjusted Mg 86.31 to 154.40 154.43 to 174.70   174.71 to 196.63   196.65 to 329.96  
aModel 1 1 (Ref) 1.61
(0.57–2.34)
0.54 1.56
(0.78–3.49)
0.32 1.25
(0.61–5.56)
0.26
bModel 2 1 (Ref) 1.32
(0.75–3.32)
0.36 1.11
(0.65–4.31)
0.41 1.09
(0.74–6.32)
0.14
cModel 3 1 (Ref) 1.88
(0.53–4.53)
0.24 2.02
(0.48–6.21)
0.34 0.93
(0.81–5.70)
0.07
dModel 4 1 (Ref) 1.60
(0.43–2.34)
0.97 0.98
(0.71–3.61)
0.25 0.89
(1.25–4.78)
0.043
  1. Data are presented as odds ratio (95 %CI)
  2. *Logistic regression
  3. acrude model
  4. bAdjusted for age and gender
  5. cAdditionally adjusted for body mass index, alcohol consumption, smoking, diabetes and physical activity
  6. dAdditionally adjusted for energy, dietary fiber, carbohydrate, fat, and protein intakes
  7. The significance level: P < 0.05